Literature DB >> 19281803

A family-based study of the IL3RA gene on susceptibility to schizophrenia in a Chinese Han population.

Shilong Sun1, Jun Wei2, Heyao Li1, Shunzi Jin1, Peng Li3, Guizhi Ju1, Ying Liu4, Xiang Yang Zhang5.   

Abstract

Schizophrenia has been observed to be associated with various abnormalities in cytokines and cytokine receptors that have been one of the recent focal points of immunological research in schizophrenia. Recent reports have showed that IL-3 gene, colony stimulating factor 2 receptor alpha (CSF2RA) and IL-3 receptor alpha (IL3RA) are associated with schizophrenia. The aim of this study was to investigate IL3RA gene variants in schizophrenia among a Chinese population by using a family-based association approach. Our sample included 101 Chinese parent-offspring trios of Han descent. All subjects were genotype for IL3RA-rs6603272 and -rs6645249 using PCR techniques. Single marker analysis showed a significant association for rs6603272 (X(2)=5.15, df=1, P=0.023), but not for the rs6645249. However, there was a significant genotypic association of both the polymorphisms with schizophrenia (for rs6603272, X(2)=6.15, df=2, P=0.046; for rs6645249, X(2)=21.79, df=2, P=1.85e-005). Haplotype TDT was statistically significant (X(2)=5.14, df=1, P=0.023), with the rs6603272(T)-rs6645249(G) haplotype significantly associated with schizophrenia (OR=1.66; 95% CI=1.08-2.55). In conclusion, our family-based association study also revealed a small but significant contribution of the IL3RA variants to susceptibility to schizophrenia in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281803     DOI: 10.1016/j.brainres.2009.02.071

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

Review 2.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

Review 3.  Genetics in schizophrenia: where are we and what next?

Authors:  Arun K Tiwari; Clement C Zai; Daniel J Müller; James L Kennedy
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

4.  Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes.

Authors:  N C Andreasen; M A Wilcox; B-C Ho; E Epping; S Ziebell; E Zeien; B Weiss; T Wassink
Journal:  Mol Psychiatry       Date:  2011-08-30       Impact factor: 15.992

Review 5.  The neuroimmunology of schizophrenia.

Authors:  Annya M Smyth; Stephen M Lawrie
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.